Assessment of quality of life in patients with visual impairments using a new visual function questionnaire: the VFQ-J11.
Assessment of quality of life in patients with visual impairments using a new visual function questionnaire: the VFQ-J11.
复制标题
DOI：
10.2147/opth.s115159
复制
发表时间：
2016
期刊：
影响因子：
--
通讯作者：
Yamada M
中科院分区：
文献类型：
--
作者：
Nakano T;Kawashima M;Hiratsuka Y;Tamura H;Ono K;Murakami A;Tsubota K;Yamada M
本研究采用日本国立眼科研究所视觉功能问卷（VFQ-J11）对视障患者的视觉相关生活质量（QOL）进行评估。采用大组不同程度损伤和各种病因的患者，与25项版本（VFQ-25）和EuroQoL指数进行比较。本研究共招募了232名来自日本6个眼科的视障患者。收集眼科检查结果和患者背景信息，并通过调查问卷收集患者的生活质量和效用评估信息。患者平均年龄69.6±14.3岁。视力相关生活质量评分（VFQ-25综合评分和VFQ-J11综合评分）与视障受试者的视敏度好坏均有显著相关（P<0.01）。无论病因如何，VFQ-J11与VFQ-25具有可比性。VFQ-25复合评分和VFQ-J11评分与一系列全身性疾病同时相关。EuroQoL指数与较好的眼VA有显著相关性（P<0.01），与较差的眼VA及其他全身性疾病无显著相关性。VFQ-J11提供了与视力相关的生活质量的有效数据，减轻了视力问题患者的负担。
The purpose of the present study was to assess the vision-related quality of life (QOL) of visually impaired patients using the Japanese 11-item National Eye Institute Visual Function Questionnaire (VFQ-J11). Comparisons with the 25-item version (VFQ-25) and the EuroQoL Index using a large group of patients with various degrees of impairments and various causative diseases were performed. A total of 232 visually impaired Japanese patients were recruited from six ophthalmology departments in Japan. Information on ophthalmic findings and patient backgrounds was collected, and information on QOL and utility assessments was collected from the patients by means of survey questionnaires. The average age of patients was 69.6±14.3 years. Both the vision-related QOL scores (VFQ-25 composite and VFQ-J11) were significantly associated with better and worse visual acuity (VA) in visually impaired subjects (all P<0.01). VFQ-J11 was comparable to VFQ-25 regardless of causative diseases. VFQ-25 composite and the VFQ-J11 scores were concurrently associated with a range of systemic medical disorders. EuroQoL Index had a significant association with better eye VA (P<0.01), but not with worse eye VA, or any systemic disorders. VFQ-J11 provides valid data on vision-related QOL and is less of a burden for patients with vision problems.